Can anyone explain why they are testing the efficacy of 5mg and 10mg dosage in XanaMIA in healthy adults, when the cognitive improvement we saw in healthy adults from XanaHES was on a 20mg dose? I'm not a scientist and won't pretend to understand, and I'm confident of course that our management know what they're doing... but can anyone explain why?
- Forums
- ASX - By Stock
- ACW
- Ann: Trading Halt
Ann: Trading Halt, page-25
-
- There are more pages in this discussion • 38 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ACW (ASX) to my watchlist
|
|||||
Last
3.7¢ |
Change
-0.002(5.13%) |
Mkt cap ! $105.7M |
Open | High | Low | Value | Volume |
3.7¢ | 3.9¢ | 3.7¢ | $108.2K | 2.913M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 2538388 | 3.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.8¢ | 718126 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 2483388 | 0.036 |
5 | 1066500 | 0.035 |
2 | 115000 | 0.034 |
3 | 280058 | 0.033 |
1 | 200000 | 0.032 |
Price($) | Vol. | No. |
---|---|---|
0.038 | 718126 | 7 |
0.039 | 683147 | 4 |
0.040 | 343128 | 6 |
0.041 | 723649 | 3 |
0.042 | 482809 | 5 |
Last trade - 11.53am 12/09/2024 (20 minute delay) ? |
Featured News
ACW (ASX) Chart |